COG — Cambridge Cognition Holdings Share News
0.000.00%
Last trade - 00:00- £15.73m
- £16.34m
- £10.34m
REG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Preliminary Unaudited Results
AnnouncementREG - Cambridge Cognition - Notice of Results and Investor Presentation
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Block Listing Return
AnnouncementRCS - Cambridge Cognition - CANTAB® used for major global brain health study
AnnouncementRCS - Cambridge Cognition - Cambridge Cognition submits FDA Letter of Intent
AnnouncementREG - Cambridge Cognition - Board Appointment
AnnouncementREG - Cambridge Cognition - Launch of in-house rater training service
AnnouncementREG - Cambridge Cognition - Expanded partnership with Actinogen
AnnouncementRCS - Cambridge Cognition - CANTAB® success in Bristol Myers Squib research
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Trading Update
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Monument Therapeutics secures £1m investment
Announcement